Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Debunking Myths in the US Healthcare System
Your Article Summary
See Latest ArticlesTreatment of chronic hepatitis delta with pegylated interferon-alpha2b
Liver International, 08/17/06
Erhardt, Andreas, et al. - Conclusion: The present study indicates that PEG-IFN-alpha2b is a promising treatment option in chronic hepatitis D. Nonresponders could be identified by a less than 3 log decrease of HDV RNA at 6 months of treatment
Related Articles
Resolution of chronic hepatitis Delta after 1 year of combined therapy with pegylated interferon, tenofovir and emtricitabine
Journal of Clinical Virology, 11/17/09
Relevance Score: 80%
Entecavir for the long-term treatment of chronic hepatitis B
Expert Review of Anti-infective Therapy, 11/09/09
Relevance Score: 69%
Therapeutic vaccination and novel strategies to treat chronic HBV infection
Expert Review of Gastroenterology & Hepatology, 10/16/09
Relevance Score: 69%
APRI as a predictor of early viral response in chronic hepatitis C patients
World Journal of Gastroenterology, 10/26/09
Relevance Score: 68%
Factors influencing long-term changes in mental health after interferon-alpha treatment of chronic hepatitis C
Alimentary Pharmacology and Therapeutics, 10/23/09
Relevance Score: 68%
Today in Antimicrobials...keeping you current
Receive free subspecialty "5-minute updates" via email
Inhibition of Herpes Simplex Virus Type 1 By the Experimental Immunosuppressive Agent Leflunomide
Transplantation, 12/16/09
Use of oseltamivir in children
Canadian Family Physician, 12/16/09
Major Study Finds Anti-HIV Gel Ineffective Among Women
National Institute of Allergy and Infectious Disease - News, 12/16/09
Today in Hepatitis...keeping you current
Receive free subspecialty "5-minute updates" via email
Screening for hepatitis B in chemotherapy patients: survey of current oncology practices
Alimentary Pharmacology and Therapeutics, 12/16/09
Evaluation of Anti-HBs Serum Levels and Pharmacokinetic Profile After Intravenous Administration of Niuliva, a New Hepatitis B Immunoglobulin, Following Liver Transplantation
Transplantation Proceedings, 12/16/09
The Benefits of Interferon Treatment in Patients Without Sustained Viral Response After Living Donor Liver Transplantation for Hepatitis C
Transplantation Proceedings, 12/16/09
Article Search
Sponsor